# Fitlife Brands, Inc.: Form 10-Q for the period ended Sep 30, 2015

- Company: [Fitlife Brands, Inc.](/companies/ftlf.md) (CIK 1374328)
- Form: 10-Q
- Filed: 2015-11-12
- Accepted by EDGAR: Nov 12, 2015, 16:21 ET
- Period: 2015-09-30
- Accession: 0001415889-15-003671
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374328/000141588915003671/ftlf10q_sept302015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374328/000141588915003671/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $6.3m | us-gaap:Revenues |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $15.1m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-07-01 to 2015-09-30 | $3.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2015-01-01 to 2015-09-30 | $9.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-07-01 to 2015-09-30 | $2.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2015-01-01 to 2015-09-30 | $6.1m | us-gaap:GrossProfit |
| Operating income | 3 months, 2015-07-01 to 2015-09-30 | $443.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2015-01-01 to 2015-09-30 | $714.8k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-07-01 to 2015-09-30 | $18.7k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2015-01-01 to 2015-09-30 | $59.3k | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | $41.2k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | $71.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | $383.3k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | $584.5k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 8,721,259 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 8,728,959 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | −$518.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $4.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2015-01-01 to 2015-09-30 | $398.2k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-09-30 | $3.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $11.2m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $12.2m | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $3.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-09-30 | $4.9m | us-gaap:Liabilities |
| Long-term debt | at 2015-09-30 | $1.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-09-30 | $520.9k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2015-09-30 | $7.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 13,537 characters.

### Forward-Looking Statements

Management’s Discussion and Analysis contains various “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to “anticipates”, “believes”, “plans”, “expects”, “future” and similar statements or expressions, identify forward looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company’s business, including but not limited to, reliance on key customers and competition in its markets, market demand, product performance, technological developments, maintenance of relationships with key suppliers, difficulties of hiring or retaining key personnel and any changes in current accounting rules, all of which may be beyond the control of the Company. The Company adopted at management’s discretion, the most conservative recognition of revenue based on the most astringent guidelines of the SEC. Management will elect additional changes to revenue recognition to comply with the most conservative SEC recognition on a forward going accrual basis as the model is replicated with other similar markets. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth therein.

Forward-looking statements involve risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those identified in the section titled “*Risk Factors”* in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, as well as other factors that we are currently unable to identify or quantify, but that may exist in the future.

In addition, the foregoing factors may affect generally our business, results of operations and financial position. Forward-looking statements speak only as of the date the statement was made. We do not undertake and specifically decline any obligation to update any forward-looking statements.

### Overview

FitLife Brands, Inc. (the “*Company”*) is a national provider of innovative and proprietary nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition Products™ (“*NDS”) (*www.ndsnutrition.com), PMD™ (www.pmdsports.com), SirenLabs™ (www.sirenlabs.com), CoreActive™ (www.coreactivenutrition.com), and Metis Nutrition™ (www.metisnutrition.com). With the consummation of the merger with iSatori, Inc. (“*iSatori”*) on September 30, 2015, which became effective on October 1, 2015, described below (the “*Merger”*), the Company added addition brands to its product portfolio, including iSatori (www.isatori.com), CT Fletcher, BioGenetic Laboratories and Energize. (together, “*iSatori Products”).* The Company’s full line of nutritional supplements support athletic performance, weight loss and general health, and are distributed through franchised General Nutrition Centers, Inc. (“*GNC”*) stores located both domestically and internationally, and, with the addition of Metis Nutrition, through corporate GNC stores in the United States and Canada. The iSatori Products are sold through more than 25,000 retail locations, which include specialty, mass, and online.

The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS Nutrition Products, Inc., a Florida corporation (“*NDS”).*

The Company is headquartered in Omaha, Nebraska. For more information on the Company, please go to www.fitlifebrands.com. The Company’s common stock currently trades under the symbol FTLF on the OTCBB market.

### Results of Operations

*Net Sales.* Revenue for the three months ended September 30, 2015 was $6,270,524 compared to $5,492,334 for the three months ended September 30, 2014, an increase of $778,190, or 14.2%. The increase in total revenue for the three month period ended September 30, 2015 was principally the result of continued strong unit movement at retail, increased sales from our established franchise-exclusive brands supported by the introduction of approximately 20 new products at the GNC franchise convention at the end of June, and strong initial demand for our newest brand, Metis Nutrition, which continued to roll-out into corporate stores throughout the third quarter. Revenue for the nine months ended September 30, 2015 decreased 15.0% to $15,139,949 as compared to $17,812,097 for the nine months ended September 30, 2014. The decrease in total revenue for the nine month period ended September 30, 2015 was principally caused by the previously discussed transition to the centralized GNC distribution platform in May and September of 2014, which had the effect of driving revenue into the first half of 2014 in anticipation of the transition.

-13-

Management believes that the backlog and supply disruptions incurred in the nine month period ended September 30, 2015 have largely been addressed, and are nonrecurring. The transition to GNC’s centralized distribution platform which established a new discounted pricing schedule placed into effect by GNC during the quarter ended June 30, 2014, which continued to affect sales during the nine month period ended September 30, 2015 compared to the comparable period in 2014, is also not anticipated to impact quarter over quarter and period over period comparisons subsequent to the year ended December 31, 2015. As discussed in prior reports, the pricing discounts impacting revenue in the quarterly periods subsequent to the quarter ended March 31, 2014 were largely offset through lower cost of goods sold and operating expenses in such periods realized in connection with the transition to the new distribution platform.

We currently market more than 60 products to over 900 GNC franchise locations both domestic and international, including the recent introduction of JXT5 under the Metis NutritionTM line for corporate stores. The Company introduced 20 new products at the GNC franchise convention, which was held in Las Vegas, NV from June 29 to July 1, 2015. The Company continually seeks to increase both the number of stores and number of approved products that comprise its domestic and international distribution footprint and, while no assurances can be given, we anticipate that such efforts, together with the introduction of additional new products, the recent launch of the Metis Nutrition line for corporate stores, and the addition of the iSatori products effective October 1, 2015 to the Company’s product portfolio, will continue to drive future revenue growth. While currently not a material component of revenue, management anticipates that continued international expansion will also be a major driver of future growth.

*Cost of Goods Sold.* Cost of goods sold for the three months ended September 30, 2015 increased to $3,658,541 as compared to $3,646,397 for the three months ended September 30, 2014, and $9,015,846 during the nine months ended September 30, 2015 as compared to $11,361,133 for the nine months ended September 30, 2014. The decrease during the three month period was principally attributable to improved pricing for certain raw material and components driven by volume discounts and management’s continued focus on cost reduction and efficiencies. The decrease during the nine month period ended September 30, 2015 was primarily attributable to lower aggregate sales volume versus the nine month period ended September 30, 2014.

*General and Administrative Expense.* General and administrative expense for the three months ended September 30, 2015 increased to $854,729 as compared to $517,417 for the three months ended September 30, 2014, an increase of $337,312, which included $250,594 of non-recurring general and administrative costs incurred in connection with the Merger during the quarter. General and administrative expense for the nine months ended September 30, 2015 increased to $2,469,866 as compared to $2,109,443 for the nine months ended September 30, 2014, an increase of $360,423, which included $502,432 of non-recurring general and administrative costs incurred in connection with the Merger during the nine month period ended September 30, 2015. Excluding non-recurring Merger-related costs, general and administrative expense for the nine months ended September 30, 2015 would have decreased $142,009 to $1,967,434. Although no assurances can be given, as we integrate the operations of iSatori, we anticipate a reduction in total general and administrative expense as a percentage of total revenue.

*Selling and Marketing Expense.* Selling and marketing expense for the three and nine months ended September 30, 2015 increased to $1,258,537 and $2,773,293, as compared to $631,643 and $1,788,521 for the three and nine months ended September 30, 2014, respectively. The increase in selling and marketing expense for the three- and nine-month period ended September 30, 2015 is principally the result of $319,337 of product rebates taken in connection with the 2015 GNC franchise convention and $127,620 related to the launch of JXT5, both of which were incurred during the three months ended September 30, 2015. The sales and marketing expense also reflects the addition of three new employees hired to support ongoing sales growth. As net sales increase, selling and marketing expense is anticipated to simultaneously increase, although management anticipates that selling and marketing expense will increase at a lower rate in subsequent periods.

*Depreciation and Amortization.* Depreciation and amortization for the three months ended September 30, 2015 decreased to $55,472 as compared to $56,508 for the three months ended September 30, 2014. Depreciation and amortization for the nine months ended September 30, 2015 decreased to $166,137 as compared to $169,405 for the nine months ended September 30, 2014.

*Net Income/(Loss).* We generated net income of $383,258 for the three months ended September 30, 2015 as compared to a profit of $564,079 for the three months ended September 30, 2014. We generated a profit of $584,533 for the nine months ended September 30, 2015 as compared to a profit of $2,182,640 for the nine months ended September 30, 2014.

-14-

### Liquidity and Capital Resources

The Company has historically financed its operations primarily through equity and debt financings, and more recently, cash flow from operations. The Company has also provided for its cash needs by issuing common stock, options and warrants for certain operating costs, including consulting and professional fees. The Company did not engage in any financing activities during the quarter ended September 30, 2015. The anticipated cash derived from operations and existing cash resources are expected to provide for the Company’s liquidity for the next 12 months.

*Cash Provided by/(Used in) Operations.* Our cash used in operating activities for the nine months ended September 30, 2015 was ($518,159), as compared to cash provided by operating activities of $630,310 for the nine months ended September 30, 2014. The decrease is principally attributable to additional expenses incurred in connection with the acquisition of iSatori and normal variations in certain working capital accounts, principally accounts receivable. Net working capital decreased to $7,414,162 as of the quarter ended September 30, 2015 from $7,682,151 as of September 30, 2014.

*Cash Provided by/(Used in) Investing Activities.* Cash used in investing activities for the nine months ended September 30, 2015 was $(402,315) as compared to $47,838 provided by investing activities for the nine months ended September 30, 2014. The primary difference was the $398,209 recorded in connection with the Company’s Repurchase Program.

*Cash Provided by/(Used in) Financing Activities.* Our cash used in financing activities for the nine months ended September 30, 2015 was $(378,561), as compared to $(365,059) cash used in financing activities during the nine months ended September 30, 2014, both of which exclusively related the repayment of principal under the Company’s existing term loan with U.S. Bank.

### WHERE YOU CAN FIND MORE INFORMATION

You are advised to read this Quarterly Report on Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

## Market risk

As filed, 1,417 characters.

Our business is currently conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although as the geographical scope of our business broadens, we may do so in the future.

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash equivalents consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.

We do not hold any derivative instruments and do not engage in any hedging activities.

-15-

## Controls and procedures

As filed, 3,998 characters.

(a) *Evaluation of Disclosure Controls and Procedures*

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives. As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control — Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“*COSO”*). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management has used the framework set forth in the report entitled Internal Control-Integrated Framework published by the COSO to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, our Chief Executive Officer and Chief Financial Officer have concluded that our internal control over financial reporting was effective as of September 30, 2015. This Quarterly Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our internal control over financial reporting was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

(b) *Changes in Internal Controls Over Financial Reporting*

There have been no changes in our internal controls over financial reporting or in other factors that could materially affect, or are reasonably likely to affect, our internal controls over financial reporting during the quarter ended September 30, 2015. There have not been any significant changes in the Company's critical accounting policies identified since the Company filed its Annual Report on Form 10-K as of December 31, 2014.

-16-

### PART II

### OTHER INFORMATION

## Risk factors

As filed, 1,176 characters.

Our results of operations and financial condition are subject to numerous risks and uncertainties disclosed in Part I, Item 1A, “*Risk Factors”* in our Annual Report on Form 10-K for the year ended December 31, 2014. You should carefully consider these risk factors in conjunction with the other information contained in this Quarterly Report. Should any of these risks materialize, our business, financial condition and future prospects could be negatively impacted.

We have identified the following risk factor in addition to the risk factors previously disclosed in Part I, Item 1A, “*Risk Factors”* in our Annual Report on Form 10-K for the year ended December 31, 2014:

### The Company faces risks associated with the acquisition of iSatori.

Our recent acquisition of iSatori may not achieve expected returns and other benefits as a result of various factors, including integration and other challenges, such as personnel and product introductions. In addition, we may not achieve anticipated cost savings resulting from the acquisition, which could result in lower gross margins, therefore materially affecting our results from operations and financial condition.

-17-

Filed Nov 12, 2015.
Source: SEC EDGAR, the filing index for accession 0001415889-15-003671. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
